Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Berek, MD MMSc
Stanford University Hospital and Clinics, Department of Obstetrics and Gynecology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona Cancer Center
Tucson, Arizona, United States
- University of San Diego
La Jolla, California, United States
- Stanford University Hospital and Clinics
Stanford, California, United States
- University of Miami
Miami, Florida, United States
- Florida Hospital Cancer Center
Orlando, Florida, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- University of Louisville Cancer Center
Louisville, Kentucky, United States
- Johns Hopkins Medical Institute
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Wayne State University
Detroit, Michigan, United States
- Dartmouth-Hitchock Medical Center
Lebanon, New Hampshire, United States
- Columbia University Cancer Center
New York, New York, United States
- Wake-Forest University
Winston-Salem, North Carolina, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- Magee Women'S Hospital, University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- the Methodist Hospital
Houston, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Dec 2009
- Completion
- 31 Aug 2010
- Last update posted
- 17 Oct 2018
- Registered enrollment
- 32
- Registry id
- NCT00326885
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.